Adial Pharmaceuticals, Inc (ADIL) News

Latest headlines that mention ADIL, newest first · each headline opens the original publisher

ADIL quote

Last price: $3.68
Day change: -6.12%
Next earnings: 2026-11-12

Quote & chart Expected move Insider trading IV rank history

ADIL headlines

latest coverage

Not much coverage yet. ADIL has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Seeking Alpha 1d ago

Adial Pharmaceuticals to appoint Celia Economides as CFO

General T2ADIL

Investing.com 11d ago

Adial Pharmaceuticals appoints David Rubenstein as chief scientist

General T3ADIL

Seeking Alpha 2mo ago

Adial Pharmaceuticals GAAP EPS of -$11.25 misses by $8.60

Earnings T2ADIL

Investing.com 3mo ago

10% owner Coastlands Capital buys $32,637 in Adial Pharmaceuticals

General T3ADIL

Investing.com 3mo ago

Coastlands Capital LP acquires $65,000 in Adial Pharmaceuticals

M&A T3ADIL

Investing.com 4mo ago

Form 4 Adial Pharmaceuticals Inc For: 16 June

General T3ADIL

Investing.com 4mo ago

Lucid Capital Markets initiates Adial Pharmaceuticals stock with buy rating on colitis drug potential

General T3ADIL LCID

Seeking Alpha 4mo ago

Adial Pharmaceuticals acquires Azora Therapeutics, secures up to $64M financing

M&A T2ADIL

Investing.com 4mo ago

Adial Pharmaceuticals acquires Azora Therapeutics for $32M

M&A T3ADIL

Investing.com 5mo ago

Form 8K Adial Pharmaceuticals Inc For: 11 May

General T3ADIL

ADIL news alerts

Get an alert by email or push when a new headline mentions ADIL.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.